Briana R. De Miranda

Author

Institute for Neurodegenerative Disorders ORCID

Also Known As

B. R. De Miranda, Briana De Miranda, Briana R De Miranda, Briana R. De Miranda, Briana R. de Miranda

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Institute for Neurodegenerative Disorders University of Pittsburgh VA Pittsburgh Healthcare System Geriatric Research Education and Clinical Center University of Alabama at Birmingham

About

Briana R. De Miranda is an author at Institute for Neurodegenerative Disorders specializing in medicine, pharmacology, and neuroprotection.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	453
2	Cell Biology	4	4	219
3	Social Sciences	3	3	228
4	Public Health	2	2	57
5	Biochemistry	2	2	74

Briana R. De Miranda

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
LRRK2 activation in idiopathic Parkinson’s disease Roberto Di Maio, Eric K. Hoffman, Emily M. Rocha, Science Translational Medicine	2018	580
LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease Emily M. Rocha, Briana R. De Miranda, Sandra L. Castro, Neurobiology of Disease MitophagyCell DeathSynaptic SignalingSocial SciencesCell Autophagy	2019	98
Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease Briana R. De Miranda, Emily M. Rocha, Qing Bai, Neurobiology of Disease Rotenone-induced NeurotoxicityMedicineCell DeathNeuropharmacologyNeuroprotection	2018	94
Sex Differences in Rotenone Sensitivity Reflect the Male-to-Female Ratio in Human Parkinson’s Disease Incidence Briana R. De Miranda, Marco Fazzari, Emily M. Rocha, Toxicological Sciences Human Parkinson ’Social SciencesNeurobiology Of DiseaseRotenone Sensitivity ReflectExperimental Neuropathology	2019	83
The Nurr1 Activator 1,1-Bis(3′-Indolyl)-1-(p-Chlorophenyl)Methane Blocks Inflammatory Gene Expression in BV-2 Microglial Cells by Inhibiting Nuclear Factor κB Briana R. De Miranda, Katriana A. Popichak, Sean L. Hammond, Molecular Pharmacology	2015	75
The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson's disease Briana R. De Miranda, Sandra L. Castro, Emily M. Rocha, Neurobiology of Disease	2021	66
Trichloroethylene, a ubiquitous environmental contaminant in the risk for Parkinson's disease Briana R. De Miranda, J. Timothy Greenamyre Environmental Science Processes & Impacts	2020	57
Neuroprotective Efficacy and Pharmacokinetic Behavior of Novel Anti-Inflammatory Para-Phenyl Substituted Diindolylmethanes in a Mouse Model of Parkinson’s Disease Briana R. De Miranda, James A. Miller, Ryan J. Hansen, Journal of Pharmacology and Experimental Therapeutics	2013	56
Novel Para-Phenyl Substituted Diindolylmethanes Protect Against MPTP Neurotoxicity and Suppress Glial Activation in a Mouse Model of Parkinson’s Disease Briana R. De Miranda, Katriana A. Popichak, Sean L. Hammond, Toxicological Sciences ImmunologyNeuroinflammationInflammationMolecular PharmacologyMptpp Model	2014	50
Long-term RNAi knockdown of α-synuclein in the adult rat substantia nigra without neurodegeneration Alevtina Zharikov, Qing Bai, Briana R. De Miranda, Neurobiology of Disease Neurodegenerative DiseasesMolecular NeuroscienceNeurobiology Of DiseaseDegenerative DiseaseLong-term Rnai Knockdown	2019	47

Page 1